NCT02386826 2023-09-21INC280 Combined With Bevacizumab in Patients With Glioblastoma MultiformeSCRI Development Innovations, LLCPhase 1 Completed65 enrolled
NCT02205398 2019-01-22Study of Safety and Efficacy of INC280 and Cetuximab, in Adult c-MET Positive mCRC and HNSCC Patients After Progression on Cetuximab or Panitumumab TherapyNovartisPhase 1 Terminated13 enrolled